Literature DB >> 11123075

Probing for genes in seronegative spondyloarthropathy.

M Stone1, M M Khraishi, P Rahman.   

Abstract

Seronegative spondyloarthropathies are a group of disorders characterized by inflammation of the spine, sacroiliac joints, and peripheral arthritis along with various characteristic extra-articular features. Their pathogenesis and immunogenetics have not yet been fully elucidated. Ankylosing Spondylitis (AS) is probably the best studied of these disease. It has now been 27 years since the association of human leukocyte antigen (HLA) B27 and AS has been demonstrated. Since then, a plethora of association studies and linkage studies unequivocally demonstrate that genetic determinants within or near the major histocompatible complex (MHC) are critical to the etiology of AS. Surprisingly though, the total MHC contribution to AS has been estimated at only 30%. In this review, we highlight the genetic basis of AS as the prototypical chronic axial arthritis, and discuss the rationale and approach in searching for non-HLA linked genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123075     DOI: 10.1007/s11926-000-0067-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  35 in total

1.  Letter: HLA B27 in blacks with ankylosing spondylitis or Reiter's disease.

Authors:  A E Good; H Kawanishi; J S Schultz
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

2.  Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia.

Authors:  L Alexeeva; M Krylov; V Vturin; N Mylov; S Erdesz; L Benevolenskaya
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

3.  A genome-wide screen for susceptibility loci in ankylosing spondylitis.

Authors:  M A Brown; K D Pile; L G Kennedy; D Campbell; L Andrew; R March; J L Shatford; D E Weeks; A Calin; B P Wordsworth
Journal:  Arthritis Rheum       Date:  1998-04

Review 4.  Genes in the spondyloarthropathies.

Authors:  P Wordsworth
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

5.  HLA-B27 subtypes positively and negatively associated with spondyloarthropathy.

Authors:  A R Nasution; A Mardjuadi; S Kunmartini; N G Suryadhana; B Setyohadi; D Sudarsono; N M Lardy; T E Feltkamp
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

6.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

7.  HIA-B27 in Mexican patients with ankylosing spondylitis.

Authors:  A Fraga; C Gorodezky; C Lavalle; L E Castro-Escobar; L Magaña; A Escobar-Gutiérrez
Journal:  Arthritis Rheum       Date:  1979-03

8.  Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis.

Authors:  B Frankenberger; S Breitkopf; E Albert; S Scholz; E Keller; M Schattenkirchner; E H Weiss; H Kellner
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

9.  Human lymphocyte antigen, HL-A27, in Japanese patients with ankylosing spondylitis.

Authors:  H Sonozaki; H Seki; S Chang; M Okuyama; T Juji
Journal:  Tissue Antigens       Date:  1975-04

10.  HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis?

Authors:  J D Reveille; M E Suarez Almazor; A S Russell; R C Go; J Appleyard; B O Barger; R T Acton; W J Koopman; D O McDaniel
Journal:  Semin Arthritis Rheum       Date:  1994-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.